Covid-19: Healthcare impacts
Anvisa’s deadlines are suspended for 120 (one hundred and twenty) days. The deadlines to accomplish the requirements relate to the following petitions for registration and post-registration of input, drugs and biological products: certification of bioequivalence centers, qualification of pharmaceutical equivalence centers, and consent and modification in clinical trials of drugs and biological products. In such […]